Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody CetuximabKimio Yonesaka, Pasi A. Jänne, Kreshnik Zejnullahu et al.|Science Translational Medicine|2011Cited by 670
Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung CancerRiichiroh Maruyama, Masahiro Fukuoka, Koji Takeda et al.|Journal of Clinical Oncology|2008Cited by 365
Extracorporeal cardiopulmonary resuscitation in adults: evidence and implicationsDarryl Abrams, Daniel Brodie, Graeme MacLaren et al.|Intensive Care Medicine|2021Cited by 252
Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary SiteHidetoshi Hayashi, Kazuhiko Nakagawa, Takayasu Kurata et al.|Journal of Clinical Oncology|2019Cited by 168
VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION IN A YOUNG MALE WITH MULTISYSTEM INFLAMMATORY SYNDROME FOLLOWING COVID-19 INFECTIONAlice Chung, Eamon Duffy, Heidi Lumish et al.|Journal of the American College of Cardiology|2023Cited by 0